Disposition Index Has Limited Direct Relevance in Type 1 Diabetes Mellitus
The disposition index (DI) is primarily a research tool for type 2 diabetes and prediabetes that has minimal clinical utility in type 1 diabetes, as T1D is fundamentally characterized by absolute or near-absolute insulin deficiency rather than the insulin resistance-secretion dynamics that DI measures.
What the Disposition Index Actually Measures
The disposition index quantifies the relationship between insulin secretion capacity and insulin sensitivity (calculated as insulin sensitivity × β-cell responsivity). It serves as the best measure of β-cell function in conditions where both insulin secretion and insulin action vary 1, 2. However, this metric was developed and validated for predicting conversion to type 2 diabetes in populations with intact but declining β-cell function 2.
Why DI Has Limited Applicability in Type 1 Diabetes
The Fundamental Problem
Type 1 diabetes is defined by autoimmune destruction of β-cells resulting in total or near-total lack of insulin secretion 3. Since DI requires measurable endogenous insulin secretion to calculate, it becomes mathematically meaningless in the vast majority of established T1D patients who have minimal to no C-peptide production.
The Insulin Resistance Component
While insulin resistance does occur in T1D patients—particularly those with obesity—the relevant clinical measures are:
- Estimated Glucose Disposal Rate (eGDR): More clinically useful for identifying insulin resistance in T1D, with values <8 mg/kg/min indicating significant insulin resistance and association with microvascular complications 4, 5
- Triglyceride-Glucose (TyG) index: Identifies T1D patients requiring higher insulin doses per kilogram, with values ≥4.68 indicating insulin resistance 4
These markers assess insulin resistance directly without requiring endogenous insulin secretion measurements, making them far more practical for T1D management.
The Only Potential Exception: Early T1D with Residual β-Cell Function
A small subset of newly diagnosed T1D patients retain residual β-cell function 3. In this narrow window:
- DI could theoretically be calculated if measurable C-peptide exists
- However, even here, the clinical utility is questionable since the trajectory is progressive β-cell loss regardless of DI values
- Research efforts focus on preserving residual function, but DI is not the standard metric used for this purpose 3
Clinical Bottom Line
For established type 1 diabetes management, ignore disposition index entirely and focus on:
- eGDR for insulin resistance assessment (calculate from HbA1c, waist circumference, and hypertension status)
- Total daily insulin requirements adjusted for weight
- Glycemic control metrics (HbA1c, time in range)
- Screening for metabolic syndrome components when insulin resistance is suspected
The disposition index belongs in type 2 diabetes research and has been inappropriately extrapolated to T1D discussions where the underlying pathophysiology makes it inapplicable 2, 6.